BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22536844)

  • 1. Thermodynamic analysis of the molecular interactions between amyloid β-protein fragments and (-)-epigallocatechin-3-gallate.
    Wang SH; Dong XY; Sun Y
    J Phys Chem B; 2012 May; 116(20):5803-9. PubMed ID: 22536844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic analysis of the molecular interactions between amyloid beta-peptide 42 and (-)-epigallocatechin-3-gallate.
    Wang SH; Liu FF; Dong XY; Sun Y
    J Phys Chem B; 2010 Sep; 114(35):11576-83. PubMed ID: 20718413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insight into conformational transition of amyloid β-peptide 42 inhibited by (-)-epigallocatechin-3-gallate probed by molecular simulations.
    Liu FF; Dong XY; He L; Middelberg AP; Sun Y
    J Phys Chem B; 2011 Oct; 115(41):11879-87. PubMed ID: 21899367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity inhibitors protect lipid membranes from disruption by Aβ42.
    Malishev R; Nandi S; Kolusheva S; Levi-Kalisman Y; Klärner FG; Schrader T; Bitan G; Jelinek R
    ACS Chem Neurosci; 2015 Nov; 6(11):1860-9. PubMed ID: 26317327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ
    Li F; Zhan C; Dong X; Wei G
    Phys Chem Chem Phys; 2021 Sep; 23(34):18843-18854. PubMed ID: 34612422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of (-)-epigallocatechin-3-gallate with human serum albumin: fluorescence, fourier transform infrared, circular dichroism, and docking studies.
    Maiti TK; Ghosh KS; Dasgupta S
    Proteins; 2006 Aug; 64(2):355-62. PubMed ID: 16705651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the mechanism of (-)-epigallocatechin-3-gallate-induced precipitation of insulin.
    Wang SH; Dong XY; Sun Y
    Int J Biol Macromol; 2012 Jun; 50(5):1229-37. PubMed ID: 22537475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of the inhibition of EGCG on the Alzheimer Aβ(1-42) dimer.
    Zhang T; Zhang J; Derreumaux P; Mu Y
    J Phys Chem B; 2013 Apr; 117(15):3993-4002. PubMed ID: 23537203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of binding interactions of (-)-epigallocatechin-3-gallate from green tea and lipase.
    Wu X; He W; Yao L; Zhang H; Liu Z; Wang W; Ye Y; Cao J
    J Agric Food Chem; 2013 Sep; 61(37):8829-35. PubMed ID: 23971865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insights into the Inhibition and Disaggregation Effects of EGCG on Aβ40 and Aβ42 Cofibrillation.
    Li X; Zhang Y; Wang Y; Zhang S; Zhang L
    J Phys Chem B; 2024 Feb; 128(8):1843-1853. PubMed ID: 38359305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting Aβ
    Zhan C; Chen Y; Tang Y; Wei G
    ACS Chem Neurosci; 2020 Jun; 11(12):1841-1851. PubMed ID: 32441920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroanalysis of the interaction between (-)-epigallocatechin-3-gallate (EGCG) and amyloid-β in the presence of copper.
    Zhang B; Cheng XR; da Silva IS; Hung VW; Veloso AJ; Angnes L; Kerman K
    Metallomics; 2013 Mar; 5(3):259-64. PubMed ID: 23443273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers.
    Lopez del Amo JM; Fink U; Dasari M; Grelle G; Wanker EE; Bieschke J; Reif B
    J Mol Biol; 2012 Aug; 421(4-5):517-24. PubMed ID: 22300765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of negatively charged hydrophobic nanoparticles and (-)-epigallocatechin-3-gallate on inhibiting amyloid β-protein aggregation.
    Liu H; Yu L; Dong X; Sun Y
    J Colloid Interface Sci; 2017 Apr; 491():305-312. PubMed ID: 28049055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of glycine zipper fragments of Aβ-peptides with neuronal nitric oxide synthase: kinetic, thermodynamic and spectrofluorimetric analysis.
    Padayachee ER; Whiteley CG
    Neuropeptides; 2013 Jun; 47(3):171-8. PubMed ID: 23375441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and theoretical studies on the binding of epigallocatechin gallate to purified porcine gastric mucin.
    Zhao Y; Chen L; Yakubov G; Aminiafshar T; Han L; Lian G
    J Phys Chem B; 2012 Nov; 116(43):13010-6. PubMed ID: 22506496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isothermal titration calorimetry study of epicatechin binding to serum albumin.
    Frazier RA; Papadopoulou A; Green RJ
    J Pharm Biomed Anal; 2006 Aug; 41(5):1602-5. PubMed ID: 16522360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into Molecular Mechanisms of EGCG and Apigenin on Disrupting Amyloid-Beta Protofibrils Based on Molecular Dynamics Simulations.
    Fang M; Zhang Q; Guan P; Su K; Wang X; Hu X
    J Phys Chem B; 2022 Oct; 126(41):8155-8165. PubMed ID: 36219848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three amyloid assembly inhibitors: the sugar scyllo-inositol, the polyphenol epigallocatechin gallate, and the molecular tweezer CLR01.
    Sinha S; Du Z; Maiti P; Klärner FG; Schrader T; Wang C; Bitan G
    ACS Chem Neurosci; 2012 Jun; 3(6):451-8. PubMed ID: 22860214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea extract EGCG plays a dual role in Aβ
    Dong X; Tang Y; Zhan C; Wei G
    Chem Phys Lipids; 2021 Jan; 234():105024. PubMed ID: 33278382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.